Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Chaperone Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
Chaperone Technologies

Chaperone Technologies

Angel

Chaperone Technologies: A biotech firm innovating peptide-based antimicrobial solutions.

HQ
Wayne, PA, US
Founded
2002
Overview
Compare
Fundraising
Employees

Chaperone Technologies is a biotechnology firm dedicated to innovating peptide-based antimicrobial solutions to combat infectious diseases. Their core mission is to develop advanced antimicrobial products that address critical healthcare challenges. The company focuses on creating effective treatments that can significantly improve patient outcomes in the infectious disease market.

Chaperone Technologies has made notable strides in the biotech industry by advancing the development of their peptide-based antimicrobial products. Their innovative approach has the potential to transform the treatment landscape for infectious diseases, contributing to better healthcare solutions globally.

Chaperone Technologies - Similar Companies

Chaperone Therapeutics logo

Chaperone Therapeutics

PhagePro logo

PhagePro

phageproinc.com

Carrisan Technologies logo

Carrisan Technologies

carrisan.com

Anti-Microbial Solutions logo

Anti-Microbial Solutions

Petri Bio logo

Petri Bio

petribio.com

Bioharmony Therapeutics logo

Bioharmony Therapeutics

Chimeron Bio logo

Chimeron Bio

ArrePath logo

ArrePath

arrepath.com

Innovative Biologics logo

Innovative Biologics

Prokaryotics logo

Prokaryotics

prokaryotics.com

Taxis Pharmaceuticals logo

Taxis Pharmaceuticals

taxispharma.com

Endolytix logo

Endolytix

Chitozan Health logo

Chitozan Health

chitozanhealth.com

ExoLytics logo

ExoLytics

exolytics.com

X-Biotix Therapeutics logo

X-Biotix Therapeutics

Chaperone Technologies - Quick Facts

Who are Chaperone Technologies' competitors?

Companies similar to Chaperone Technologies include Chaperone Therapeutics, PhagePro, Carrisan Technologies and Anti-Microbial Solutions.

When was Chaperone Technologies founded?

Chaperone Technologies was founded in 2002.

Where is Chaperone Technologies' headquarters located?

Chaperone Technologies' headquarters is located in Wayne, PA, US.

When was Chaperone Technologies' last funding round?

Chaperone Technologies' most recent funding round was for $100k (USD) in March 2006.

How much has Chaperone Technologies raised to-date?

As of Mar 6, 2006, Chaperone Technologies has raised a total of $100k (USD).

How many employees does Chaperone Technologies have?

Chaperone Technologies has 5 employees as of Feb 4, 2024.

Chaperone Technologies - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antimicrobial Products
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations